EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability

William Jin iD, Christopher Montoya iD, Benjamin James Rich iD, Crystal Seldon Taswell iD, Miguel Noy iD, Deukwoo Kwon iD, Benjamin Spieler iD, Brandon Mahal iD, Matthew Abramowitz iD, Raphael Yechieli iD, Alan Pollack iD, Alan Dal Pra iD

JMIR Cancer · 10.09.2024 · 10 · e51061

DOI: 10.2196/51061 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift JMIR Cancer, online erschienen am 10.09.2024. Verfasst von William Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Jackson Memorial Hospital, Miami, FL, United States. Hauptthemen laut MEDLINE: Feasibility Studies, Prostatic Neoplasms, Mobile Applications, Patient Compliance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with prostate cancer undergoing radiation therapy (RT) need comfortably full bladders to reduce toxicities during treatment. Poor compliance is common with standard of care written or verbal instructions, leading to wasted patient value (PV) and clinic resources via poor throughput efficiency (TE).

Objective

Herein, we assessed the feasibility and acceptability of a smartphone-based behavioral intervention (SBI) to improve bladder-filling compliance and methods for quantifying PV and TE.

Methods

In total, 36 patients with prostate cancer were enrolled in a single-institution, closed-access, nonrandomized feasibility trial. The SBI consists of a fully automated smart water bottle and smartphone app. Both pieces alert the patient to empty his bladder and drink a personalized volume goal, based on simulation bladder volume, 1.25 hours before his scheduled RT. Patients were trained to adjust their volume goal and notification times to achieve comfortably full bladders. The primary end point was met if qualitative (QLC) and quantitative compliance (QNC) were >80%. For QLC, patients were asked if they prepared their bladders before daily RT. QNC was met if bladder volumes on daily cone-beam tomography were >75% of the simulation’s volume. The Service User Technology Acceptability Questionnaire (SUTAQ) was given in person pre- and post-SBI. Additional acceptability and engagement end points were met if >3 out of 5 across 4 domains on the SUTAQ and >80% (15/18) of patients used the device >50% of the time, respectively. Finally, the impact of SBI on PV and TE was measured by time spent in a clinic and on the linear accelerator (linac), respectively, and contrasted with matched controls.

Results

QLC was 100% in 375 out of 398 (94.2%) total treatments, while QNC was 88.9% in 341 out of 398 (85.7%) total treatments. Of a total score of 5, patients scored 4.33 on privacy concerns, 4 on belief in benefits, 4.56 on satisfaction, and 4.24 on usability via SUTAQ. Further, 83% (15/18) of patients used the SBI on >50% of treatments. Patients in the intervention arm spent less time in a clinic (53.24, SEM 1.71 minutes) compared to the control (75.01, SEM 2.26 minutes) group (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesProstatic NeoplasmsMobile ApplicationsPatient ComplianceHumansMaleAgedMiddle AgedUrinary BladderSmartphoneAged, 80 and over

Stichwörter der Autor:innen

behavioral interventionbladdercompanion appcompliancedigital healthdigital therapeuticsmobile phoneoncologyprivacyprostateprostate cancerradiationradiation therapysmart water bottlesmartphone-based behavioral intervention

Autor:innen und Institutionen

  • Department of Radiation Oncology, Jackson Memorial Hospital, Miami, FL, United States.
  • Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health Systems, Miami, FL, United States.
  • Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, United States.

ORCID-Profile: William Jin, Christopher Montoya, Benjamin James Rich, Crystal Seldon Taswell, Miguel Noy, Deukwoo Kwon, Benjamin Spieler, Brandon Mahal, Matthew Abramowitz, Raphael Yechieli, Alan Pollack, Alan Dal Pra

Zitieren

APA

Jin, W., Montoya, C., Rich, B. J., Taswell, C. S., Noy, M., Kwon, D., Spieler, B., Mahal, B., Abramowitz, M., Yechieli, R., Pollack, A., & Dal Pra, A. (2024). A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability. JMIR Cancer, 10, e51061. https://doi.org/10.2196/51061

Vancouver

Jin W, Montoya C, Rich BJ, Taswell CS, Noy M, Kwon D, et al. A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability. JMIR Cancer. 2024;10:e51061. doi:10.2196/51061

BibTeX
@article{Jin2024,
  author = {Jin, William and Montoya, Christopher and Rich, Benjamin James and Taswell, Crystal Seldon and Noy, Miguel and Kwon, Deukwoo and Spieler, Benjamin and Mahal, Brandon and Abramowitz, Matthew and Yechieli, Raphael and Pollack, Alan and Dal Pra, Alan},
  title = {A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability},
  journal = {JMIR Cancer},
  year = {2024},
  volume = {10},
  pages = {e51061},
  doi = {10.2196/51061}
}
Kostenlos starten →